DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 1 May 2026 · 21 days left
In plain terms
The US Defense Health Agency funds clinical research and trials on arthritis prevention, early diagnosis, and treatment through its Fiscal Year 2026 Arthritis Research Program, with awards supporting two levels of research complexity. Applications from any type of US organisation or individual are welcome, and the deadline is 22 October 2026.
A generated summary of the donor's text; the original wording is below.
Summary
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged.
Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden.
Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research.
• Research Level 1: Applications proposing clinical research or early-phase/pilot clinical trials, to include new or emerging research that is not ready for a full-scale randomized controlled clinical trial.
• Research Level 2: Applications proposing a full-scale clinical trial.
Applications should include a community collaborator (e.g., patient/care partner, community-based organization consultant) who will provide advice and consultation during study…
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- ngo_cso
- academia_research
- private_company
- government
- individual
- community_based_org
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"